Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance.
Ontology highlight
ABSTRACT: Insulin resistance is a cornerstone of obesity-related complications such as type 2 diabetes, metabolic syndrome, and nonalcoholic fatty liver disease. A high rate of lipolysis is known to be associated with insulin resistance, and inhibiting adipose tissue lipolysis improves obesity-related insulin resistance. Here, we demonstrate that inhibition of serotonin (5-hydroxytryptamine [5-HT]) signaling through serotonin receptor 2B (HTR2B) in adipose tissues ameliorates insulin resistance by reducing lipolysis in visceral adipocytes. Chronic high-fat diet (HFD) feeding increased Htr2b expression in epididymal white adipose tissue, resulting in increased HTR2B signaling in visceral white adipose tissue. Moreover, HTR2B expression in white adipose tissue was increased in obese humans and positiv
SUBMITTER: Choi WG
PROVIDER: S-EPMC8631597 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA